标题
Trial watch: peptide-based vaccines in anticancer therapy
作者
关键词
-
出版物
OncoImmunology
Volume -, Issue -, Pages 1-15
出版商
Informa UK Limited
发表日期
2018-09-07
DOI
10.1080/2162402x.2018.1511506
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Regulation of the Cell Biology of Antigen Cross-Presentation
- (2018) J. Magarian Blander Annual Review of Immunology
- Vaccine therapy in hematologic malignancies
- (2018) David Avigan et al. BLOOD
- HER2-Based Immunotherapy for Breast Cancer
- (2018) Naipeng Cui et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Personalized cancer vaccines: adjuvants are important, too
- (2018) Cécile Gouttefangeas et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunotherapy-based combinations
- (2018) Giovanni Fucà et al. CURRENT OPINION IN ONCOLOGY
- Immunogenic Apoptosis as a Novel Tool for Anticancer Vaccine Development
- (2018) Barbara Montico et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy
- (2018) Yared Hailemichael et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent Cervical Cancer
- (2018) Kosei Hasegawa et al. JOURNAL OF IMMUNOTHERAPY
- Immunotherapy: Local chemotherapy synergizes with CTLA-4 inhibition
- (2018) Peter Sidaway Nature Reviews Clinical Oncology
- PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
- (2018) Michael R. Migden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies
- (2018) Michael Rückert et al. STRAHLENTHERAPIE UND ONKOLOGIE
- BAP31, a newly defined cancer/testis antigen, regulates proliferation, migration, and invasion to promote cervical cancer progression
- (2018) Erle Dang et al. Cell Death & Disease
- NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
- (2018) Remy Thomas et al. Frontiers in Immunology
- Approaches to Improve Chemically Defined Synthetic Peptide Vaccines
- (2018) Brett J. Hos et al. Frontiers in Immunology
- Targeting Head and Neck Cancer by Vaccination
- (2018) Chuan Wang et al. Frontiers in Immunology
- Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity
- (2018) Chen-Yi Chiang et al. Frontiers in Immunology
- Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer
- (2018) Maarten Versteven et al. Frontiers in Immunology
- Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy
- (2018) Yugang Guo et al. Frontiers in Immunology
- Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma
- (2018) Manh-Cuong Vo et al. Frontiers in Immunology
- TFAM is a novel mediator of immunogenic cancer cell death
- (2018) Minghua Yang et al. OncoImmunology
- Epigenetic anticancer agents cause HMGB1 release in vivo
- (2018) Peng Liu et al. OncoImmunology
- eIF2α phosphorylation: A hallmark of immunogenic cell death
- (2018) Lucillia Bezu et al. OncoImmunology
- Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma
- (2018) Carter M. Suryadevara et al. OncoImmunology
- The intestinal microbiota determines the clinical efficacy of immune checkpoint blockers targeting PD-1/PD-L1
- (2018) Lisa Derosa et al. OncoImmunology
- Virus-like particle display of HER2 induces potent anti-cancer responses
- (2018) Arianna Palladini et al. OncoImmunology
- Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4+ T cells expressing converged T-cell receptor genes in vitro
- (2018) Miki Tsuruta et al. OncoImmunology
- Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial
- (2018) Hansje-Eva Teulings et al. OncoImmunology
- TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas
- (2018) Tsuyoshi Hamada et al. OncoImmunology
- The possibility of cancer immune editing in gliomas. A critical review
- (2018) Víctor A. Arrieta et al. OncoImmunology
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
- (2018) André Kahles et al. CANCER CELL
- Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine
- (2018) Hiroaki Shima et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Epidermal growth factor receptor peptide vaccination induces cross-reactive immunity to human EGFR, HER2, and HER3
- (2018) Hester A. Doyle et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Emerging strategies for combination checkpoint modulators in cancer immunotherapy
- (2018) Aleksandra Popovic et al. JOURNAL OF CLINICAL INVESTIGATION
- Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response
- (2017) Atefeh Arab et al. IMMUNOLOGIC RESEARCH
- Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses
- (2017) Abhishek D. Garg et al. IMMUNOLOGICAL REVIEWS
- Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance
- (2017) Norma Bloy et al. IMMUNOLOGICAL REVIEWS
- A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens
- (2017) Aaron Y. Chang et al. JOURNAL OF CLINICAL INVESTIGATION
- A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice
- (2017) Atefeh Arab et al. JOURNAL OF DRUG TARGETING
- Dendritic cell and antigen dispersal landscapes regulate T cell immunity
- (2017) Michael Y. Gerner et al. JOURNAL OF EXPERIMENTAL MEDICINE
- NY-ESO-1 Protein Cancer Vaccine With Poly-ICLC and OK-432
- (2017) Tomohira Takeoka et al. JOURNAL OF IMMUNOTHERAPY
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- The benefits of immunotherapy combinations
- (2017) Charles Schmidt NATURE
- Cancer: Precision T-cell therapy targets tumours
- (2017) Cornelis J. M. Melief NATURE
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Chimeric antigen receptor T-cell therapies for lymphoma
- (2017) Jennifer N. Brudno et al. Nature Reviews Clinical Oncology
- Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
- (2017) Sattva S. Neelapu et al. Nature Reviews Clinical Oncology
- Personalized peptide vaccines and their relation to other therapies in urological cancer
- (2017) Takahiro Kimura et al. Nature Reviews Urology
- Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition
- (2017) Arlene Siefker-Radtke et al. Nature Reviews Urology
- CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner
- (2017) L Huang et al. ONCOGENE
- Telomerase based anticancer immunotherapy and vaccines approaches
- (2017) Chahal Kailashiya et al. VACCINE
- Predictors of responses to immune checkpoint blockade in advanced melanoma
- (2017) N. Jacquelot et al. Nature Communications
- Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy
- (2017) Guizhi Zhu et al. Nature Communications
- Adjuvants
- (2017) M. Juliana McElrath Current Opinion in HIV and AIDS
- Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting
- (2017) Annacarmen Petrizzo et al. Oncotarget
- Barriers to Radiation-Induced In Situ Tumor Vaccination
- (2017) Erik Wennerberg et al. Frontiers in Immunology
- Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators
- (2017) Yong Qin et al. Frontiers in Immunology
- PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
- (2017) Sylvain Simon et al. OncoImmunology
- Dendritic cell vaccine induces antigen-specific CD8+ T cells that are metabolically distinct from those of peptide vaccine and is well-combined with PD-1 checkpoint blockade
- (2017) Koji Nagaoka et al. OncoImmunology
- Cellular immunotherapies for cancer
- (2017) Pedro Berraondo et al. OncoImmunology
- Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications
- (2017) Mariona Cabo et al. OncoImmunology
- PD-L1 inhibitors in the pipeline: Promise and progress
- (2017) Vito Vanella et al. OncoImmunology
- Trial Watch: Adoptively transferred cells for anticancer immunotherapy
- (2017) Carole Fournier et al. OncoImmunology
- Immunosurveillance and immunoediting in MMTV-PyMT-induced mammary oncogenesis
- (2017) Emilie T. E. Gross et al. OncoImmunology
- Blinatumomab bridges the gap between leukemia and immunity
- (2017) Takahiro Yamazaki et al. OncoImmunology
- No patient left behind: The promise of immune priming with epigenetic agents
- (2017) Corey A. Carter et al. OncoImmunology
- Trial watch: DNA-based vaccines for oncological indications
- (2017) Stefano Pierini et al. OncoImmunology
- Acquisition of tumor cell phenotypic diversity along the EMT spectrum under hypoxic pressure: Consequences on susceptibility to cell-mediated cytotoxicity
- (2017) Stéphane Terry et al. OncoImmunology
- PD-L1 blockade for urothelial carcinoma
- (2017) Josephine Kang et al. OncoImmunology
- Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells
- (2017) Hiroaki Shime et al. OncoImmunology
- Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
- (2017) Abhishek D. Garg et al. OncoImmunology
- Trial watch: Immune checkpoint blockers for cancer therapy
- (2017) Claire Vanpouille-Box et al. OncoImmunology
- Lack of MHC class II molecules favors CD8+ T-cell infiltration into tumors associated with an increased control of tumor growth
- (2017) Nada Chaoul et al. OncoImmunology
- A library-based screening method identifies neoantigen-reactive T cells in peripheral blood prior to relapse of ovarian cancer
- (2017) Spencer D. Martin et al. OncoImmunology
- A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer
- (2017) Patrick M. Dillon et al. Journal for ImmunoTherapy of Cancer
- Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)
- (2016) P. Saiag et al. ANNALS OF ONCOLOGY
- A phase I/II study of cancer peptide vaccine S-288310 in patients with advanced urothelial carcinoma of the bladder
- (2016) W Obara et al. ANNALS OF ONCOLOGY
- Gardasil-9: A global survey of projected efficacy
- (2016) Lukai Zhai et al. ANTIVIRAL RESEARCH
- Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases
- (2016) Ileana S. Mauldin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases
- (2016) Ileana S. Mauldin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Basis of Oncoimmunology
- (2016) A. Karolina Palucka et al. CELL
- Immune targets and neoantigens for cancer immunotherapy and precision medicine
- (2016) Rong-Fu Wang et al. CELL RESEARCH
- Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response
- (2016) M. I. E. van Poelgeest et al. CLINICAL CANCER RESEARCH
- Neoantigens encoded in the cancer genome
- (2016) Ton N Schumacher et al. CURRENT OPINION IN IMMUNOLOGY
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- (2016) Christina Pfirschke et al. IMMUNITY
- The present status and future prospects of peptide-based cancer vaccines
- (2016) Masatoshi Hirayama et al. INTERNATIONAL IMMUNOLOGY
- Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles
- (2016) Eleni Maria Varypataki et al. JOURNAL OF CONTROLLED RELEASE
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2016) Johan F Vansteenkiste et al. LANCET ONCOLOGY
- Neoantigen landscape dynamics during human melanoma–T cell interactions
- (2016) Els M. E. Verdegaal et al. NATURE
- Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
- (2016) Kelly D Moynihan et al. NATURE MEDICINE
- The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
- (2016) Danny N. Khalil et al. Nature Reviews Clinical Oncology
- Combine and conquer: challenges for targeted therapy combinations in early phase trials
- (2016) Juanita S. Lopez et al. Nature Reviews Clinical Oncology
- Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations
- (2016) Axel Hoos NATURE REVIEWS DRUG DISCOVERY
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- The Human Vaccines Project: A roadmap for cancer vaccine development
- (2016) Pedro Romero et al. Science Translational Medicine
- Enhancing PD-1 Blockade in Solid Tumors
- (2016) Cancer Discovery
- Protective effect of telomerase-based 16-mer peptide vaccine (GV1001) on inferior epigastric island skin flap survivability in ischaemia-reperfusion injury rat model
- (2016) Yung Ki Lee et al. Journal of Plastic Surgery and Hand Surgery
- Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence
- (2016) Elizabeth A. Mittendorf et al. Oncotarget
- Immunological Mechanisms Underneath the Efficacy of Cancer Therapy
- (2016) L. Galluzzi et al. Cancer Immunology Research
- Trial Watch: Immunotherapy plus radiation therapy for oncological indications
- (2016) Erika Vacchelli et al. OncoImmunology
- CAR-T cell therapy in gastrointestinal tumors and hepatic carcinoma: From bench to bedside
- (2016) Qi Zhang et al. OncoImmunology
- Immunotherapies targeting CD38 in Multiple Myeloma
- (2016) Djordje Atanackovic et al. OncoImmunology
- Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ERpos/HER2pos early breast cancer
- (2016) Lea Lowenfeld et al. OncoImmunology
- Chemotherapy and immunotherapy: A close interplay to fight cancer?
- (2016) Aurélie Hanoteau et al. OncoImmunology
- Rapid tumor regression in an Asian lung cancer patient following personalized neo-epitope peptide vaccination
- (2016) Fenge Li et al. OncoImmunology
- Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope
- (2016) P. Baumgaertner et al. OncoImmunology
- Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy
- (2016) Aitziber Buqué et al. OncoImmunology
- Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
- (2016) Yu Sawada et al. OncoImmunology
- TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer
- (2016) Lauren V. Wood et al. OncoImmunology
- PD-1/PD-L1 inhibitors in multiple myeloma: The present and the future
- (2016) T. Jelinek et al. OncoImmunology
- Concurrent SPECT/PET-CT imaging as a method for tracking adoptively transferred T-cells in vivo
- (2016) Sasha E. Stanton et al. Journal for ImmunoTherapy of Cancer
- Hormesis, cell death and aging
- (2016) Isabelle Martins et al. Aging-US
- WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides
- (2015) Jason Brayer et al. AMERICAN JOURNAL OF HEMATOLOGY
- Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses
- (2015) P. Mitchell et al. ANNALS OF ONCOLOGY
- Small Molecules for Immunomodulation in Cancer: A Review
- (2015) Vidhya Iyer Anti-Cancer Agents in Medicinal Chemistry
- A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites
- (2015) Craig L. Slingluff et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model
- (2015) Maria Tagliamonte et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity
- (2015) Claire Vanpouille-Box et al. CANCER RESEARCH
- Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS-PC Study
- (2015) Hiroki Yamaue et al. CANCER SCIENCE
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy
- (2015) L. Zhai et al. CLINICAL CANCER RESEARCH
- Gardasil 9 joins the fight against cervix cancer
- (2015) Jack Cuzick Expert Review of Vaccines
- Anti-CD27 Antibody Potentiates Antitumor Effect of Dendritic Cell–Based Vaccine in Prostate Cancer–Bearing Mice
- (2015) Si-Ming Wei et al. INTERNATIONAL SURGERY
- Therapeutic cancer vaccines
- (2015) Cornelis J.M. Melief et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor neoantigens: building a framework for personalized cancer immunotherapy
- (2015) Matthew M. Gubin et al. JOURNAL OF CLINICAL INVESTIGATION
- Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group–American College of Radiology Imaging Network Cancer Research Group (E4697)
- (2015) David H. Lawson et al. JOURNAL OF CLINICAL ONCOLOGY
- B Cell–Intrinsic IDO1 Regulates Humoral Immunity to T Cell–Independent Antigens
- (2015) Rahul Shinde et al. JOURNAL OF IMMUNOLOGY
- Landscape of Tumor Antigens in T Cell Immunotherapy
- (2015) S. Ilyas et al. JOURNAL OF IMMUNOLOGY
- Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer
- (2015) Jean-Louis Pujol et al. Journal of Thoracic Oncology
- Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
- (2015) Cornelia L Trimble et al. LANCET
- Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial
- (2015) Daniel P Petrylak et al. LANCET ONCOLOGY
- Natural and therapy-induced immunosurveillance in breast cancer
- (2015) Guido Kroemer et al. NATURE MEDICINE
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Therapeutic HPV vaccine holds promise
- (2015) David Killock Nature Reviews Clinical Oncology
- Novel immunotherapies in lymphoid malignancies
- (2015) Connie Lee Batlevi et al. Nature Reviews Clinical Oncology
- Combination cancer immunotherapies tailored to the tumour microenvironment
- (2015) Mark J. Smyth et al. Nature Reviews Clinical Oncology
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- Big opportunities for small molecules in immuno-oncology
- (2015) Jerry L. Adams et al. NATURE REVIEWS DRUG DISCOVERY
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Vaccines, Adjuvants, and Dendritic Cell Activators—Current Status and Future Challenges
- (2015) Joseph Obeid et al. SEMINARS IN ONCOLOGY
- Agonists of Co-stimulation in Cancer Immunotherapy Directed Against CD137, OX40, GITR, CD27, CD28, and ICOS
- (2015) Miguel F. Sanmamed et al. SEMINARS IN ONCOLOGY
- Mannan-modified adenovirus targeting TERT and VEGFR-2: A universal tumour vaccine
- (2015) Ying Wang et al. Scientific Reports
- Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one
- (2015) Daniela Fenoglio et al. Human Vaccines & Immunotherapeutics
- Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma
- (2015) R. L. Sabado et al. Cancer Immunology Research
- Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
- (2015) Abhishek D. Garg et al. Frontiers in Immunology
- Trial Watch: Peptide-based anticancer vaccines
- (2015) Jonathan Pol et al. OncoImmunology
- Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients
- (2015) Neil L Berinstein et al. OncoImmunology
- Classification of current anticancer immunotherapies
- (2015) Lorenzo Galluzzi et al. Oncotarget
- Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC
- (2014) H. Okada et al. CLINICAL CANCER RESEARCH
- Vaccine-Induced Tumor Necrosis Factor-Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death
- (2014) T. C. van der Sluis et al. CLINICAL CANCER RESEARCH
- Personalized Peptide Vaccine for Treatment of Advanced Cancer
- (2014) Tetsuro Sasada et al. CURRENT MEDICINAL CHEMISTRY
- The HER2 peptide nelipepimut-S (E75) vaccine (NeuVax™) in breast cancer patients at risk for recurrence: correlation of immunologic data with clinical response
- (2014) Erika J Schneble et al. Immunotherapy
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- A vaccine targeting mutant IDH1 induces antitumour immunity
- (2014) Theresa Schumacher et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Therapeutic vaccines for cancer: an overview of clinical trials
- (2014) Ignacio Melero et al. Nature Reviews Clinical Oncology
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peptide-based vaccines for cancer therapy
- (2014) Giorgio Parmiani et al. Human Vaccines & Immunotherapeutics
- Trial Watch
- (2014) Fernando Aranda et al. OncoImmunology
- Enhanced cross-priming of naive CD8+T cells by dendritic cells treated by the IMiDs®immunomodulatory compounds lenalidomide and pomalidomide
- (2013) Jake Y. Henry et al. IMMUNOLOGY
- Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma
- (2013) Wim H.J. Kruit et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune system targeting by biodegradable nanoparticles for cancer vaccines
- (2013) Joana M. Silva et al. JOURNAL OF CONTROLLED RELEASE
- HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
- (2013) Mariette I E van Poelgeest et al. Journal of Translational Medicine
- Cutaneous melanoma
- (2013) Alexander MM Eggermont et al. LANCET
- Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
- (2013) Charles Butts et al. LANCET ONCOLOGY
- Lenalidomide enhances the protective effect of a therapeutic vaccine and reverses immune suppression in mice bearing established lymphomas
- (2013) I Sakamaki et al. LEUKEMIA
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Prospects of combinatorial synthetic peptide vaccine-based immunotherapy against cancer
- (2013) Ramon Arens et al. SEMINARS IN IMMUNOLOGY
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Tailor-Made Renal Cell Carcinoma Vaccines
- (2012) Glenn Dranoff CANCER CELL
- Next-generation peptide vaccines for advanced cancer
- (2012) Akira Yamada et al. CANCER SCIENCE
- Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: Low-burst release is crucial for efficient CD8+ T cell activation
- (2012) A.L. Silva et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
- (2012) Alfons JM van den Eertwegh et al. LANCET ONCOLOGY
- Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
- (2012) Steffen Walter et al. NATURE MEDICINE
- Combination of vaccine plus ipilimumab—safety and toxicity
- (2012) Padmanee Sharma et al. Nature Reviews Urology
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial Watch: Monoclonal antibodies in cancer therapy
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Targeting PD-1/PD-L1 interactions for cancer immunotherapy
- (2012) Laurence Zitvogel et al. OncoImmunology
- Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantation
- (2011) H. E. Kohrt et al. BLOOD
- Adjuvants for Enhancing the Immunogenicity of Whole Tumor Cell Vaccines
- (2011) Cheryl Lai-Lai Chiang et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Tumor control versus adverse events with targeted anticancer therapies
- (2011) Dorothy M. K. Keefe et al. Nature Reviews Clinical Oncology
- gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
- (2011) Douglas J. Schwartzentruber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
- (2009) Gemma G. Kenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Specificity in cancer immunotherapy
- (2008) Andrea Schietinger et al. SEMINARS IN IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started